跳转至内容
Merck
CN

332607

Sigma-Aldrich

(2-羟丙基)-β-环糊精

average Mw ~1,460

别名:

(2-羟丙基)-β-环糊精, HP-β-CD

登录查看公司和协议定价


About This Item

EC 号:
UNSPSC代码:
12352201
PubChem化学物质编号:
NACRES:
NA.22

表单

powder

质量水平

旋光性

[α]25/D +135°, c = 1 in H2O (typical)

分子量

average Mw ~1,460

标记范围

0.8 molar substitution

mp

267 °C (dec.)

溶解性

water: 180 g/L

SMILES字符串

CC(O)COCC1OC2OC3C(COCC(C)O)OC(OC4C(COCC(C)O)OC(OC5C(COCC(C)O)OC(OC6C(COCC(C)O)OC(OC7C(COCC(C)O)OC(OC8C(COCC(C)O)OC(OC1C(OCC(C)O)C2OCC(C)O)C(OCC(C)O)C8OCC(C)O)C(OCC(C)O)C7OCC(C)O)C(OCC(C)O)C6OCC(C)O)C(OCC(C)O)C5OCC(C)O)C(OCC(C)O)C4OCC(C)O)C(OCC(C)O)C3OCC(C)O

InChI

1S/C63H112O42/c1-22(64)8-85-15-29-50-36(71)43(78)57(92-29)100-51-30(16-86-9-23(2)65)94-59(45(80)38(51)73)102-53-32(18-88-11-25(4)67)96-61(47(82)40(53)75)104-55-34(20-90-13-27(6)69)98-63(49(84)42(55)77)105-56-35(21-91-14-28(7)70)97-62(48(83)41(56)76)103-54-33(19-89-12-26(5)68)95-60(46(81)39(54)74)101-52-31(17-87-10-24(3)66)93-58(99-50)44(79)37(52)72/h22-84H,8-21H2,1-7H3/t22?,23?,24?,25?,26?,27?,28?,29-,30-,31?,32?,33?,34?,35?,36?,37-,38?,39-,40+,41+,42+,43?,44+,45?,46+,47+,48+,49+,50+,51+,52-,53-,54-,55-,56-,57+,58-,59+,60-,61-,62-,63-/m1/s1

InChI key

ODLHGICHYURWBS-RYJYQAAZSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

(2-羟丙基)-β-环糊精是一种羟烷基衍生物,经证可作为一种制剂载体,增强药物在水溶液中的溶解度,从而将药物成功递送至生物系统。通常用作α-、β-和γ-环糊精的替代物。

应用

(2-羟丙基)-β-环糊精可用于:
  • 作为薄层色谱法(TLC)测定药物制剂中分析物的分析标准品。
  • 在使用反相高效液相色谱(RP-HPLC)定量之前,研究宿主-客体的有机低分子量化合物相互作用。
  • 作为HPLC法有效分离β-咔啉的流动相添加剂。
  • 环糊精修饰的胶束电动色谱(CD-modified MEKC)测定盐酸舍曲林及与合成相关产物。

亲脂性药物的溶解度随着水溶液中的羟丙基-β-环糊精(HP-β-CD)浓度线性增加,这是因为HP-β-CD与药物形成了复合物。这种客体-宿主型复合物在药物与HP-β-CD的非极性空穴间形成,导致溶解度增强。HP-β-CD可用于制备与罗哌卡因(RVC)形成的包合物,以增加RVC溶解度,确保有效的药物递送。
亲脂性药物的溶解度随着水溶液中的羟丙基-β-环糊精(HBC)浓度线性增加,这是因为HBC与药物形成了复合物。这种客体-宿主型复合物在药物与HBC的非极性空穴间形成,导致溶解度增强。 可以将溶液冻干以产生易溶的粉末。 对家兔和小鼠无毒性。

储存分类代码

13 - Non Combustible Solids

WGK

WGK 1

闪点(°F)

>752.0 °F

闪点(°C)

> 400 °C

个人防护装备

Eyeshields, Gloves, type N95 (US)


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Daniele R de Araujo et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 33(1), 60-71 (2007-11-27)
Ropivacaine (RVC) is an enantiomerically pure local anesthetic (LA) largely used in surgical procedures, which presents physico-chemical and therapeutic properties similar to those of bupivacaine (BPV), but associated to less systemic toxicity. This study focuses on the development and pharmacological
Chromatographic Separation and Purification of Novel Drug Excipient 2-Hydroxypropyl-beta-Cyclodextrin [J]
Yimin Z, et al.
Chinese Journal of Analytical Chemistry, 5 (2006)
K Miyake et al.
Pharmaceutical development and technology, 5(3), 399-407 (2000-08-10)
The object of this study was to enhance the solubility, dissolution rate, and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CyD). The interaction of rutin with cyclodextrins (CyDs) was evaluated by the solubility, and ultraviolet (UV) and circular dichroism
Björn-Hendrik Peters et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 95, 72-81 (2016-05-26)
Microscale freeze-drying makes rapid process cycles possible for early-stage formulation development. To investigate the effects of equipment scale and cooling rate on the solid state properties and the protein's secondary structure of a sample, three binary formulations of catalase were
S E Lucangioli et al.
Journal of chromatography. A, 871(1-2), 207-215 (2000-03-29)
In this work development, optimization and validation of a cyclodextrin-modified micellar electrokinetic chromatography (CD-modified MEKC) method is proposed to resolve separation of the sertraline hydrochloride and synthesis-related substances. Sertraline hydrochloride, the cis-(1S,4S) enantiomer form, is used as an antidepressant therapeutic

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门